Trial intelligence / Profile preview

GRACE

NCT03769844Phase 4Completed

Sponsor
Nationwide Children's Hospital
Start
Dec 2018
Primary completion
Dec 2023
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of sargramostim in multiple organ dysfunction syndrome (MODS), sponsored by Nationwide Children's Hospital. Started Dec 2018; status: completed.

02

Drugs

sargramostim
03

Conditions

multiple organ dysfunction syndrome (MODS)

Beyond the preview

Go deeper on NCT03769844.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03769844.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call